WallStSmart
NVST

Envista Holdings Corp

NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$25.90
-2.23% today

Updated 2026-04-29

Market cap
$4.22B
P/E ratio
92.50
P/S ratio
1.55x
EPS (TTM)
$0.28
Dividend yield
52W range
$16 – $30
Volume
2.4M

Envista Holdings Corp (NVST) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$2.74B$2.79B$2.81B$2.84B$2.28B$1.93B$2.51B$2.57B$2.57B$2.51B$2.72B
Revenue growth (YoY)+1.8%+0.9%+1.2%-19.7%-15.6%+30.1%+2.4%-0.1%-2.2%+8.3%
Cost of revenue$1.21B$1.17B$1.18B$1.23B$933.10M$856.00M$1.05B$1.08B$2.25B$1.12B$1.22B
Gross profit$1.52B$1.61B$1.63B$1.61B$1.35B$1.07B$1.46B$1.49B$1.44B$1.39B$1.50B
Gross margin55.6%57.9%57.9%56.6%59.2%55.6%58.3%57.9%56.1%55.4%55.0%
R&D$142.80M$172.40M$172.00M$133.10M$86.70M$100.50M$100.10M$93.80M$99.10M$114.00M
SG&A$1.04B$1.06B$1.06B$1.13B$1.08B$1.02B$1.02B$1.06B$1.05B$1.14B$1.14B
Operating income$350.00M$402.80M$386.60M$298.40M$235.70M$43.50M$306.20M$319.20M$31.50M$-1.04B$225.70M
Operating margin12.8%14.5%13.8%10.5%10.3%2.3%12.2%12.4%1.2%-41.4%8.3%
EBITDA$563.30M$543.90M$454.80M$377.00M$260.20M$496.00M$497.70M$31.50M$279.50M$341.70M
EBITDA margin0.0%20.2%19.3%16.0%16.5%13.5%19.8%19.4%1.2%11.1%12.6%
EBIT$436.10M$422.50M$324.80M$248.50M$127.60M$372.40M$359.90M$31.50M$156.40M$225.70M
Interest expense$0.00$0.00$0.00$0.00$3.50M$62.50M$54.10M$38.40M$63.40M$46.40M$36.60M
Income tax$75.00M$129.70M$85.60M$70.40M$49.60M$-62.50M$-9.00M$45.90M$45.30M$33.90M$130.20M
Effective tax rate21.4%32.3%22.1%23.4%18.6%214.0%-2.7%15.9%-82.5%-3.1%73.5%
Net income$275.50M$272.00M$301.10M$230.70M$217.60M$33.30M$340.50M$243.10M$-100.20M$-1.12B$47.00M
Net income growth (YoY)-1.3%+10.7%-23.4%-5.7%-84.7%+922.5%-28.6%-141.2%-1016.4%+104.2%
Profit margin10.1%9.8%10.7%8.1%9.5%1.7%13.6%9.5%-3.9%-44.6%1.7%